SPL 1.08% 9.4¢ starpharma holdings limited

Ann: US patent issued for DEP cabazitaxel nanoparticle, page-30

  1. 34 Posts.
    lightbulb Created with Sketch. 28
    Interesting to read that Allergan (AbbVie) co-funded this study with Starpharma. Hopefully they like what they see and they’ll license it off us in the not too distant future.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.